Benjamin Netanyahu revealed that he had been diagnosed with prostate cancer and underwent treatment without making the information public for nearly two months. The disclosure came after the completion of his treatment, which included radiation therapy to remove a small tumour detected in its early stage.
The 76-year-old stated that this was the first time he had been diagnosed with cancer. He explained that the decision to delay sharing his medical condition was deliberate, aimed at preventing adversaries, particularly Iran, from using the information for propaganda purposes during the ongoing conflict. He made the announcement through a social media post, providing details about his diagnosis and recovery.
Early Detection and Immediate Treatment Decision
According to Benjamin Netanyahu, doctors identified a tumour measuring less than one centimetre in the prostate during a routine medical examination. The cancer was classified as early-stage malignant and had not spread to other parts of the body, which significantly improved the chances of successful treatment.
He said that doctors presented him with two options: to monitor the tumour over time or to proceed with immediate treatment. Choosing not to delay, he opted for radiation therapy to eliminate the tumour. He emphasized his approach to health decisions, stating that when risks are identified early, prompt action is essential.
Netanyahu added that he continued to carry out his official duties during the course of treatment. Despite undergoing therapy sessions, he maintained his work schedule, holding meetings and managing responsibilities. He described the treatment phase as manageable and indicated that the condition is now behind him.
He also expressed gratitude to his medical team and used the opportunity to encourage the public to prioritize regular health check-ups and follow medical advice. In his message, he extended a broader appeal for health awareness, including a reference to people in Iran, urging them to take care of their well-being.
Previous Medical History and Surgical Intervention
Netanyahu’s recent treatment follows a prior medical procedure related to the prostate. In December 2024, he underwent surgery at the Hadassah Medical Center to address an enlarged prostate condition. At that time, doctors reported that the surgery was successful and indicated no immediate signs of cancer.
Medical experts involved in the earlier procedure, including urology specialists, had stated that the prostate was removed and the patient had responded well to the surgery. Regular follow-up examinations were conducted after the operation, which eventually led to the detection of the small tumour in a subsequent check-up.
Over the years, Netanyahu has faced various health concerns but has continued to remain active in public life. During earlier legal proceedings, he had mentioned maintaining a demanding work schedule, often working extended hours daily.
Understanding Prostate Cancer and Its Impact
Prostate cancer is among the most common cancers affecting men worldwide. According to global estimates, approximately 1.4 million cases are diagnosed each year. The condition primarily affects men over the age of 50, although it can occur in younger individuals in certain cases.
The disease often develops slowly and may not show symptoms in its early stages. However, if left undetected, it can spread to other organs such as the bladder, liver, lungs, and bones. Advanced stages of prostate cancer can lead to severe complications, including chronic pain and reduced mobility due to bone involvement.
Treatment options for prostate cancer vary depending on the stage and severity of the disease. These may include active surveillance, radiation therapy, hormone therapy, or surgical removal of the prostate gland. While these treatments can be effective, they may also have side effects, including impacts on fertility and sexual health.
Hormone therapy, for instance, can reduce testosterone levels, leading to potential complications such as erectile dysfunction. Radiation therapy may also affect reproductive capabilities. In cases where surgery is required, doctors often recommend precautionary measures such as sperm preservation, especially for younger patients who may wish to have children in the future.
Global Context and Other High-Profile Cases
Prostate cancer has affected several high-profile individuals globally, highlighting the widespread nature of the disease. Joe Biden was also diagnosed with prostate cancer, with his condition becoming public in May 2025. In his case, the disease had already progressed and spread to the bones, making it more serious.
Medical experts note that early detection plays a crucial role in improving survival rates and treatment outcomes. Routine screenings, including prostate-specific antigen (PSA) tests and physical examinations, can help identify the disease at an early stage when it is most treatable.
The exact causes of prostate cancer remain unclear, but several risk factors have been identified. These include age, genetic predisposition, hormonal imbalances, dietary habits, lifestyle factors, and environmental influences. A combination of these elements can increase the likelihood of developing the disease.
Health Awareness and Preventive Measures
Netanyahu’s disclosure has drawn attention to the importance of health transparency and preventive care, particularly for conditions that may not present immediate symptoms. Medical professionals emphasize the value of regular check-ups, especially for individuals in higher-risk age groups.
Awareness campaigns around prostate cancer aim to encourage early screening and reduce stigma associated with discussing men’s health issues. Timely diagnosis not only improves treatment success but also minimizes the need for aggressive interventions.
The case also highlights how public figures can influence health awareness by sharing their experiences. By discussing his diagnosis and treatment, Netanyahu has contributed to broader conversations around cancer detection and management.
As medical advancements continue to improve diagnostic and treatment capabilities, the focus remains on early intervention and informed decision-making. The integration of public awareness, healthcare access, and timely medical response is essential in addressing the global burden of prostate cancer.
